64
Views
55
CrossRef citations to date
0
Altmetric
Clinical Science Review

Pathology of the Future: Molecular Profiling for Targeted Therapy

, , , , &
Pages 36-46 | Published online: 11 Jun 2009

References

  • Beske, O E.; Goldbard, S. High-throughput cell analysis using multiplexed array technologies. Drug Discov. Today 2002, 18 (Suppl 7), S131–S135.
  • Hoos, A.; Nissan, A.; Stojadinovic, A.; Shia, J.; Hedvat, C V.; Leung, D H.; Paty, P B.; Klimstra, D.; Cordon-Cardo, C.; Wong, W D. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin. Cancer Res. 2002, 12 (8), 3841–3849.
  • Hunter, T. Signaling-2000 and beyond. Cell 2000, 1 (100), 113–127. [CROSSREF]
  • Ideker, T.; Thorsson, V.; Ranish, J A.; Christmas, R.; Buhler, J.; Eng, J K.; Bumgarner, R.; Goodlett, D R.; Aebersold, R.; Hood, L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 5518 (292), 929–934. [CROSSREF]
  • Miller, L D.; Long, P M.; Wong, L.; Mukherjee, S.; McShane, L M.; Liu, E T. Optimal gene expression analysis by microarrays. Cancer Cell 2002, 5 (2), 353–361. [CROSSREF]
  • Hunter, T. The croonian lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond., B Biol. Sci. 1998, 1368 (353), 583–605. [CROSSREF]
  • Knezevic, V.; Leethanakul, C.; Bichsel, V E.; Worth, J M.; Prabhu, V V.; Gutkind, J S.; Liotta, L A.; Munson, P J.; Petricoin, E F., III; Krizman, D B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 10 (1), 1271–1288. [CROSSREF]
  • Liotta, L.; Petricoin, E. Molecular profiling of human cancer. Nat. Rev., Genet. 2000, 1 (1), 48–56. [CROSSREF]
  • Petricoin, E F.; Zoon, K C.; Kohn, E C.; Barrett, J C.; Liotta, L A. Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev., Drug Discov. 2002, 9 (1), 683–695. [CROSSREF]
  • Michener, C M.; Ardekani, A M.; Petricoin, E F., III; Liotta, L A.; Kohn, E C. Genomics and proteomics: application of novel technology to early detection and prevention of cancer. Cancer Detect. Prev. 2002, 4 (26), 249–255. [CROSSREF]
  • Celis, J E.; Gromov, P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003, 1 (3), 9–15. [CROSSREF]
  • Pandey, A.; Mann, M. Proteomics to study genes and genomes. Nature 2000, 6788 (405), 837–846.
  • Petricoin, E F.; Ardekani, A M.; Hitt, B A.; Levine, P J.; Fusaro, V A.; Steinberg, S M.; Mills, G B.; Simone, C.; Fishman, D A.; Kohn, E C.; Liotta, L A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 9306 (359), 572–577. [CROSSREF]
  • Petricoin, E F., III; Ornstein, D K.; Paweletz, C P.; Ardekani, A.; Hackett, P S.; Hitt, B A.; Velassco, A.; Trucco, C.; Wiegand, L.; Wood, K.; Simone, C B.; Levine, P J.; Linehan, W M.; Emmert-Buck, M R.; Steinberg, S M.; Kohn, E C.; Liotta, L A. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 2002, 20 (94), 1576–1578.
  • Liotta, L A.; Espina, V.; Mehta, A I.; Calvert, V.; Rosenblatt, K.; Geho, D.; Munson, P J.; Young, L.; Wulfkuhle, J.; Petricoin, E F Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 4 (3), 317–325., [CROSSREF]
  • Holland, J F. Cancer Medicine, 4th Ed.; Williams & Wilkins: Baltimore, 1997, 2 v, (xxx, 3386, 81).
  • Vose, J M. Current approaches to the management of non-Hodgkin's lymphoma. Semin. Oncol. 1998, 4 (25), 483–491.
  • Staudt, L M. Gene expression profiling of lymphoid malignancies. Annu. Rev. Med. 2002, 53, 303–318. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Liotta, L A.; Kohn, E C. The microenvironment of the tumour-host interface. Nature 2001, 6835 (411), 375–379. [CROSSREF]
  • Reed, J C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 1999, 9 (17), 2941–2953.
  • Reed, J C. Apoptosis-targeted therapies for cancer. Cancer Cell 2003, 1 (3), 17–22. [CROSSREF]
  • Evans, W E.; Relling, M V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999, 5439 (286), 487–491. [CROSSREF]
  • Schwartz, D R.; Kardia, S L.; Shedden, K A.; Kuick, R.; Michailidis, G.; Taylor, J M.; Misek, D E.; Wu, R.; Zhai, Y.; Darrah, D M.; Reed, H.; Ellenson, L H.; Giordano, T J.; Fearon, E R.; Hanash, S M.; Cho, K R. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 2002, 16 (62), 4722–4729.
  • Batorfi, J.; Ye, B.; Mok, S C.; Cseh, I.; Berkowitz, R S.; Fulop, V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol. Oncol. 2003, 3 (88), 424–428. [CROSSREF]
  • MacDonald, T J.; Brown, K M.; LaFleur, B.; Peterson, K.; Lawlor, C.; Chen, Y.; Packer, R J.; Cogen, P.; Stephan, D A. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat. Genet. 2001, 2 (29), 143–152. [CROSSREF]
  • Pomeroy, S L.; Tamayo, P.; Gaasenbeek, M.; Sturla, L M.; Angelo, M.; McLaughlin, M E.; Kim, J Y.; Goumnerova, L C.; Black, P M.; Lau, C.; Allen, J C.; Zagzag, D.; Olson, J M.; Curran, T.; Wetmore, C.; Biegel, J A.; Poggio, T.; Mukherjee, S.; Rifkin, R.; Califano, A.; Stolovitzky, G.; Louis, D N.; Mesirov, J P.; Lander, E S.; Golub, T R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 6870 (415), 436–442. [CROSSREF]
  • Perou, C M.; Sorlie, T.; Eisen, M B.; van de Rijn, M.; Jeffrey, S S.; Rees, C A.; Pollack, J R.; Ross, D T.; Johnsen, H.; Akslen, L A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S X.; Lonning, P E.; Borresen-Dale, A L.; Brown, P O.; Botstein, D. Molecular portraits of human breast tumours. Nature 2000, 6797 (406), 747–752. [CROSSREF]
  • Sorlie, T.; Perou, C M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M B.; van de Rijn, M.; Jeffrey, S S.; Thorsen, T.; Quist, H.; Matese, J C.; Brown, P O.; Botstein, D.; Eystein Lonning, P.; Borresen-Dale, A L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 19 (98), 10869–10874. [CROSSREF]
  • van 't Veer, L J.; Dai, H.; van de Vijver, M J.; He, Y D.; Hart, A A.; Mao, M.; Peterse, H L.; van der Kooy, K.; Marton, M J.; Witteveen, A T.; Schreiber, G J.; Kerkhoven, R M.; Roberts, C.; Linsley, P S.; Bernards, R.; Friend, S H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 6871 (415), 530–536. [CROSSREF]
  • West, M.; Blanchette, C.; Dressman, H.; Huang, E.; Ishida, S.; Spang, R.; Zuzan, H.; Olson, J A., Jr.; Marks, J R.; Nevins, J R. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2001, 20 (98), 11462–11467. [CROSSREF]
  • Hedenfalk, I.; Duggan, D.; Chen, Y.; Radmacher, M.; Bittner, M.; Simon, R.; Meltzer, P.; Gusterson, B.; Esteller, M.; Kallioniemi, O P.; Wilfond, B.; Borg, A.; Trent, J. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 2001, 8 (344), 539–548. [CROSSREF]
  • Gruvberger, S.; Ringner, M.; Chen, Y.; Panavally, S.; Saal, L H.; Borg, A.; Ferno, M.; Peterson, C.; Meltzer, P S. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001, 16 (61), 5979–5984.
  • Alon, U.; Barkai, N.; Notterman, D A.; Gish, K.; Ybarra, S.; Mack, D.; Levine, A J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 1999, 12 (96), 6745–6750. [CROSSREF]
  • Lin, Y M.; Furukawa, Y.; Tsunoda, T.; Yue, C T.; Yang, K C.; Nakamura, Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002, 26 (21), 4120–4128. [CROSSREF]
  • Zou, T T.; Selaru, F M.; Xu, Y.; Shustova, V.; Yin, J.; Mori, Y.; Shibata, D.; Sato, F.; Wang, S.; Olaru, A.; Deacu, E.; Liu, T C.; Abraham, J M.; Meltzer, S J. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002, 31 (21), 4855–4862. [CROSSREF]
  • Takahashi, M.; Rhodes, D R.; Furge, K A.; Kanayama, H.; Kagawa, S.; Haab, B B.; Teh, B T. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. U. S. A. 2001, 17 (98), 9754–9759. [CROSSREF]
  • Chen, X.; Cheung, S T.; So, S.; Fan, S T.; Barry, C.; Higgins, J.; Lai, K M.; Ji, J.; Dudoit, S.; Ng, I O.; Van De Rijn, M.; Botstein, D.; Brown, P O. Gene expression patterns in human liver cancers. Mol. Biol. Cell 2002, 6 (13), 1929–1939. [CROSSREF]
  • Beer, D G.; Kardia, S L.; Huang, C C.; Giordano, T J.; Levin, A M.; Misek, D E.; Lin, L.; Chen, G.; Gharib, T G.; Thomas, D G.; Lizyness, M L.; Kuick, R.; Hayasaka, S.; Taylor, J M.; Iannettoni, M D.; Orringer, M B.; Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 2002, 8 (8), 816–824. [PUBMED], [INFOTRIEVE], [CSA]
  • Bhattacharjee, A.; Richards, W G.; Staunton, J.; Li, C.; Monti, S.; Vasa, P.; Ladd, C.; Beheshti, J.; Bueno, R.; Gillette, M.; Loda, M.; Weber, G.; Mark, E J.; Lander, E S.; Wong, W.; Johnson, B E.; Golub, T R.; Sugarbaker, D J.; Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 2001, 24 (98), 13790–13795. [CROSSREF]
  • Garber, M E.; Troyanskaya, O G.; Schluens, K.; Petersen, S.; Thaesler, Z.; Pacyna-Gengelbach, M.; van de Rijn, M.; Rosen, G D.; Perou, C M.; Whyte, R I.; Altman, R B.; Brown, P O.; Botstein, D.; Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U. S. A. 2001, 24 (98), 13784–13789. [CROSSREF]
  • Welsh, J B.; Zarrinkar, P P.; Sapinoso, L M.; Kern, S G.; Behling, C A.; Monk, B J.; Lockhart, D J.; Burger, R A.; Hampton, G M. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 2001, 3 (98), 1176–1181. [CROSSREF]
  • Weng, S K.G.; Hammond, P W.; Lohse, P.; Rise, C.; Wagner, R W.; Wright, M C.; Kuimelis, R G. Generating addressable protein microarrays with PROfusion covalent mRNA-protein fusion technology. Proteomics 2002, 1 (2), 48–57. [CROSSREF]
  • Jazaeri, A A.; Yee, C J.; Sotiriou, C.; Brantley, K R.; Boyd, J.; Liu, E T. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J. Natl. Cancer Inst. 2002, 13 (94), 990–1000.
  • Dhanasekaran, S M.; Barrette, T R.; Ghosh, D.; Shah, R.; Varambally, S.; Kurachi, K.; Pienta, K J.; Rubin, M A.; Chinnaiyan, A M. Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 6849 (412), 822–826. [CROSSREF]
  • LaTulippe, E.; Satagopan, J.; Smith, A.; Scher, H.; Scardino, P.; Reuter, V.; Gerald, W L. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002, 15 (62), 4499–4506.
  • Singh, D.; Febbo, P G.; Ross, K.; Jackson, D G.; Manola, J.; Ladd, C.; Tamayo, P.; Renshaw, A A.; D'Amico, A V.; Richie, J P.; Lander, E S.; Loda, M.; Kantoff, P W.; Golub, T R.; Sellers, W R. Geneexpression correlates of clinical prostate cancer behavior. Cancer Cell 2002, 2 (1), 203–209. [CROSSREF]
  • Welsh, J B.; Sapinoso, L M.; Su, A I.; Kern, S G.; Wang-Rodriguez, J.; Moskaluk, C A.; Frierson, H F., Jr.; Hampton, G M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001, 16 (61), 5974–5978.
  • Hippo, Y.; Taniguchi, H.; Tsutsumi, S.; Machida, N.; Chong, J M.; Fukayama, M.; Kodama, T.; Aburatani, H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 1 (62), 233–240.
  • Yeoh, E J.; Ross, M E.; Shurtleff, S A.; Williams, W K.; Patel, D.; Mahfouz, R.; Behm, F G.; Raimondi, S C.; Relling, M V.; Patel, A.; Cheng, C.; Campana, D.; Wilkins, D.; Zhou, X.; Li, J.; Liu, H.; Pui, C H.; Evans, W E.; Naeve, C.; Wong, L.; Downing, J R. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 2 (1), 133–143. [CROSSREF]
  • Ferrando, A A.; Neuberg, D S.; Staunton, J.; Loh, M L.; Huard, C.; Raimondi, S C.; Behm, F G.; Pui, C H.; Downing, J R.; Gilliland, D G.; Lander, E S.; Golub, T R.; Look, A T. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1 (1), 75–87. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Alizadeh, A A.; Eisen, M B.; Davis, R E.; Ma, C.; Lossos, I S.; Rosenwald, A.; Boldrick, J C.; Sabet, H.; Tran, T.; Yu, X.; Powell, J I.; Yang, L.; Marti, G E.; Moore, T.; Hudson, J., Jr.; Lu, L.; Lewis, D B.; Tibshirani, R.; Sherlock, G.; Chan, W C.; Greiner, T C.; Weisenburger, D D.; Armitage, J O.; Warnke, R.; Staudt, L M.; , et al Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 6769 (403), 503–511.
  • Rosenwald, A.; Wright, G.; Chan, W C.; Connors, J M.; Campo, E.; Fisher, R I.; Gascoyne, R D.; Muller-Hermelink, H K.; Smeland, E B.; Giltnane, J M.; Hurt, E M.; Zhao, H.; Averett, L.; Yang, L.; Wilson, W H.; Jaffe, E S.; Simon, R.; Klausner, R D.; Powell, J.; Duffey, P L.; Longo, D L.; Greiner, T C.; Weisenburger, D D.; Sanger, W G.; Dave, B J.; Lynch, J C.; Vose, J.; Armitage, J O.; Montserrat, E.; Lopez-Guillermo, A.; Grogan, T M.; Miller, T P.; LeBlanc, M.; Ott, G.; Kvaloy, S.; Delabie, J.; Holte, H.; Krajci, P.; Stokke, T.; Staudt, L M. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002, 25 (346), 1937–1947.
  • Shipp, M A.; Ross, K N.; Tamayo, P.; Weng, A P.; Kutok, J L.; Aguiar, R C.; Gaasenbeek, M.; Angelo, M.; Reich, M.; Pinkus, G S.; Ray, T S.; Koval, M A.; Last, K W.; Norton, A.; Lister, T A.; Mesirov, J.; Neuberg, D S.; Lander, E S.; Aster, J C.; Golub, T R. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 2002, 1 (8), 68–74.
  • Chen, S T.; Pan, T L.; Tsai, Y C.; Huang, C M. Proteomics reveals protein profile changes in doxorubicin–treated MCF-7 human breast cancer cells. Cancer Lett. 2002, 1 (181), 95–107. [CROSSREF]
  • Venter, J C.; Adams, M D.; Myers, E W.; Li, P W.; Mural, R J.; Sutton, G G.; Smith, H O.; Yandell, M.; Evans, C A.; Holt, R A.; Gocayne, J D.; Amanatides, P.; Ballew, R M.; Huson, D H.; Wortman, J R.; Zhang, Q.; Kodira, C D.; Zheng, X H.; Chen, L.; Skupski, M.; Subramanian, G.; Thomas, P D.; Zhang, J.; Gabor Miklos, G L.; Nelson, C.; Broder, S.; Clark, A G.; Nadeau, J.; McKusick, V A.; Zinder, N.; Levine, A J.; Roberts, R J.; Simon, M.; Slayman, C.; Hunkapiller, M.; Bolanos, R.; Delcher, A.; Dew, I.; Fasulo, D.; Flanigan, M.; Florea, L.; Halpern, A.; Hannenhalli, S.; Kravitz, S.; Levy, S.; Mobarry, C.; Reinert, K.; Remington, K.; Abu-Threideh, J.; Beasley, E.; Biddick, K.; Bonazzi, V.; Brandon, R.; Cargill, M.; Chandramouliswaran, I.; Charlab, R.; Chaturvedi, K.; Deng, Z.; Di Francesco, V.; Dunn, P.; Eilbeck, K.; Evangelista, C.; Gabrielian, A E.; Gan, W.; Ge, W.; Gong, F.; Gu, Z.; Guan, P.; Heiman, T J.; Higgins, M E.; Ji, R R.; Ke, Z.; Ketchum, K A.; Lai, Z.; Lei, Y.; Li, Z.; Li, J.; Liang, Y.; Lin, X.; Lu, F.; Merkulov, G V.; Milshina, N.; Moore, H M.; Naik, A K.; Narayan, V A.; Neelam, B.; Nusskern, D.; Rusch, D B.; Salzberg, S.; Shao, W.; Shue, B.; Sun, J.; Wang, Z.; Wang, A.; Wang, X.; Wang, J.; Wei, M.; Wides, R.; Xiao, C.; Yan, C.; Yao, A.; Ye, J.; Zhan, M.; Zhang, W.; Zhang, H.; Zhao, Q.; Zheng, L.; Zhong, F.; Zhong, W.; Zhu, S.; Zhao, S.; Gilbert, D.; Baumhueter, S.; Spier, G.; Carter, C.; Cravchik, A.; Woodage, T.; Ali, F.; An, H.; Awe, A.; Baldwin, D.; Baden, H.; Barnstead, M.; Barrow, I.; Beeson, K.; Busam, D.; Carver, A.; Center, A.; Cheng, M L.; Curry, L.; Danaher, S.; Davenport, L.; Desilets, R.; Dietz, S.; Dodson, K.; Doup, L.; Ferriera, S.; Garg, N.; Gluecksmann, A.; Hart, B.; Haynes, J.; Haynes, C.; Heiner, C.; Hladun, S.; Hostin, D.; Houck, J.; Howland, T.; Ibegwam, C.; Johnson, J.; Kalush, F.; Kline, L.; Koduru, S.; Love, A.; Mann, F.; May, D.; McCawley, S.; McIntosh, T.; McMullen, I.; Moy, M.; Moy, L.; Murphy, B.; Nelson, K.; Pfannkoch, C.; Pratts, E.; Puri, V.; Qureshi, H.; Reardon, M.; Rodriguez, R.; Rogers, Y H.; Romblad, D.; Ruhfel, B.; Scott, R.; Sitter, C.; Smallwood, M.; Stewart, E.; Strong, R.; Suh, E.; Thomas, R.; Tint, N N.; Tse, S.; Vech, C.; Wang, G.; Wetter, J.; Williams, S.; Williams, M.; Windsor, S.; Winn-Deen, E.; Wolfe, K.; Zaveri, J.; Zaveri, K.; Abril, J F.; Guigo, R.; Campbell, M J.; Sjolander, K V.; Karlak, B.; Kejariwal, A.; Mi, H.; Lazareva, B.; Hatton, T.; Narechania, A.; Diemer, K.; Muruganujan, A.; Guo, N.; Sato, S.; Bafna, V.; Istrail, S.; Lippert, R.; Schwartz, R.; Walenz, B.; Yooseph, S.; Allen, D.; Basu, A.; Baxendale, J.; Blick, L.; Caminha, M.; Carnes-Stine, J.; Caulk, P.; Chiang, Y H.; Coyne, M.; Dahlke, C.; Mays, A.; Dombroski, M.; Donnelly, M.; Ely, D.; Esparham, S.; Fosler, C.; Gire, H.; Glanowski, S.; Glasser, K.; Glodek, A.; Gorokhov, M.; Graham, K.; Gropman, B.; Harris, M.; Heil, J.; Henderson, S.; Hoover, J.; Jennings, D.; Jordan, C.; Jordan, J.; Kasha, J.; Kagan, L.; Kraft, C.; Levitsky, A.; Lewis, M.; Liu, X.; Lopez, J.; Ma, D.; Majoros, W.; McDaniel, J.; Murphy, S.; Newman, M.; Nguyen, T.; Nguyen, N.; Nodell, M.; Pan, S.; Peck, J.; Peterson, M.; Rowe, W.; Sanders, R.; Scott, J.; Simpson, M.; Smith, T.; Sprague, A.; Stockwell, T.; Turner, R.; Venter, E.; Wang, M.; Wen, M.; Wu, D.; Wu, M.; Xia, A.; Zandieh, A.; Zhu, X. The sequence of the human genome. Science 2001, 5507 (291), 1304–1351. [CROSSREF]
  • Liebler, D C. Intoduction to Proteomics: Tools for the New Biology; Humana Press: Totowa, NJ, 2002; 15–24.
  • Chen, G.; Gharib, T G.; Huang, C C.; Thomas, D G.; Shedden, K A.; Taylor, J M.; Kardia, S L.; Misek, D E.; Giordano, T J.; Iannettoni, M D.; Orringer, M B.; Hanash, S M.; Beer, D G. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 2002, 7 (8), 2298–2305.
  • Sreekumar, A.; Nyati, M K.; Varambally, S.; Barrette, T R.; Ghosh, D.; Lawrence, T S.; Chinnaiyan, A M. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 2001, 20 (61), 7585–7593.
  • Oltvai, Z N.; Barabasi, A L. Systems biology. Life's complexity pyramid. Science 2002, 5594 (298), 763–764. [CROSSREF]
  • Milo, R.; Shen-Orr, S.; Itzkovitz, S.; Kashtan, N.; Chklovskii, D.; Alon, U. Network motifs: simple building blocks of complex networks. Science 2002, 5594 (298), 824–827. [CROSSREF]
  • Ge, H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res. 2000, 2 (28), e3, [CROSSREF]
  • Suh, Y. Cell signaling in aging and apoptosis. Mech. Ageing Dev. 2002, 8 (123), 881–890. [CROSSREF]
  • Strehler, B L.; Freeman, M R. Randomness, redundancy and repair: roles and relevance to biological aging. Mech. Ageing Dev. 1980, 1–2 (14), 15–38. [CROSSREF]
  • Haddad, J J. Cytokines and related receptor-mediated signaling pathways. Biochem. Biophys. Res. Commun. 2002, 4 (297), 700–713. [CROSSREF]
  • Harari, D.; Yarden, Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 2000, 53 (19), 6102–6114. [CROSSREF]
  • Nabholtz, J M.; Reese, D M.; Lindsay, M A.; Riva, A. HER2-positivebreast cancer: update on breast cancer international research group trials. Clin. Breast Cancer 2002, 3 (Suppl 2), S75–S79. [PUBMED], [INFOTRIEVE]
  • Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling. Nature 2001, 6835 (411), 355–365. [CROSSREF]
  • Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z N.; Barabasi, A L. The large-scale organization of metabolic networks. Nature 2000, 6804 (407), 651–654.
  • Paweletz, C P.; Charboneau, L.; Bichsel, V E.; Simone, N L.; Chen, T.; Gillespie, J W.; Emmert-Buck, M R.; Roth, M J.; Petricoin, I E.; Liotta, L A. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 16 (20), 1981–1989. [CSA], [CROSSREF]
  • Emmert-Buck, M R.; Bonner, R F.; Smith, P D.; Chuaqui, R F.; Zhuang, Z.; Goldstein, S R.; Weiss, R A.; Liotta, L A. Laser capture microdissection. Science 1996, 5289 (274), 998–1001. [CROSSREF]
  • Lal, S P.; Christopherson, R I.; dos Remedios, C G. Antibody arrays: an embryonic but rapidly growing technology. Drug Discov. Today 2002, 18 (Suppl 7), S143–S149. [CROSSREF]
  • Simone, N L.; Remaley, A T.; Charboneau, L.; Petricoin, E F., III; Glickman, J W.; Emmert-Buck, M R.; Fleisher, T A.; Liotta, L A. Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am. J. Pathol. 2000, 2 (156), 445–452.
  • Charboneau, L. Utility of reverse phase protein arrays: applications to signaling pathways and human body arrays. Brief. Funct. Genomics Proteomics 2002, 3 (1), 305–315.
  • King, G.; Payne, S.; Walker, F.; Murray, G I. A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J. Pathol. 1997, 2 (183), 237–241. [CROSSREF]
  • Bobrow, M N.; Harris, T D.; Shaughnessy, K J.; Litt, G J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 1989, 1–2 (125), 279–285. [CROSSREF]
  • Bobrow, M N.; Shaughnessy, K J.; Litt, G J. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J. Immunol. Methods 1991, 1 (137), 103–112. [CROSSREF]
  • Hunyady, B.; Krempels, K.; Harta, G.; Mezey, E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J. Histochem. Cytochem. 1996, 12 (44), 1353–1362.
  • Ring, A E.; Ellis, P A. Predictors of response to systemic therapy in breast cancer. Forum (Genova) 2002, 1 (12), 19–32.
  • Ross, J S.; Fletcher, J A. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 1998, 6 (16), 413–428.
  • Weinstein, R S.; Descour, M R.; Liang, C.; Bhattacharyya, A K.; Graham, A R.; Davis, J R.; Scott, K M.; Richter, L.; Krupinski, E A.; Szymus, J.; Kayser, K.; Dunn, B E. Telepathology overview: from concept to implementation. Human Pathol. 2001, 12 (32), 1283–1299. [CROSSREF]
  • Kaplan, K J.; Burgess, J R.; Sandberg, G D.; Myers, C P.; Bigott, T R.; Greenspan, R B. Use of robotic telepathology for frozen-section diagnosis: a retrospective trial of a telepathology system for intraoperative consultation. Mod. Path. 2002, 11 (15), 1197–1204. [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.